Ellen He
Impact in
- Oncology top 10%
- Lung Cancer Research Studies
- Colorectal Cancer Screening and Detection
- Pathology and Forensic Medicine top 10%
- Cancer Mechanisms and Therapy
Papers in
- Oncology 18
- Global Cancer Incidence and Screening 6
- Lung Cancer Research Studies 6
- Inflammatory Biomarkers in Disease Prognosis 4
- Cancer Diagnosis and Treatment 4
- Colorectal Cancer Screening and Detection 3
- Co-authors
- Sven Skog (36 shared papers)Ji Zhou (27 shared papers)Staffan Eriksson (6 shared papers)Yan Chen (3 shared papers)Siamak Haghdoost (3 shared papers)Guozhu Hu (3 shared papers)Lili Tang (2 shared papers)Qun-Li Shi (3 shared papers)
In The Last Decade
Ellen He
39 papers receiving 608 citations
Peers
Comparison fields: 5 of 51
- Oncology 205
- Pathology and Forensic Medicine 126
- Cancer Research 84
- Pulmonary and Respiratory Medicine 143
- Obstetrics and Gynecology 30
Countries citing papers authored by Ellen He
This map shows the geographic impact of Ellen He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen He more than expected).
Fields of papers citing papers by Ellen He
This network shows the impact of papers produced by Ellen He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen He. The network helps show where Ellen He may publish in the future.
Co-authors
The 25 scholars most cited alongside Ellen He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 67 | |
| 2 | 2010 | 48 | |
| 3 | 2011 | 47 | |
| 4 | 2010 | 38 | |
| 5 | 2016 | 35 | |
| 6 | 2010 | 33 | |
| 7 | Serological thymidine kinase 1 (STK1) indicates an elevated risk for the development of malignant tumours. | 2009 | 31 |
| 8 | 2022 | 30 | |
| 9 | 2011 | 27 | |
| 10 | 2012 | 26 | |
| 11 | 2013 | 23 | |
| 12 | 2013 | 22 | |
| 13 | 2010 | 20 | |
| 14 | Elevated serum thymidine kinase 1 predicts risk of pre/early cancerous progression. | 2011 | 19 |
| 15 | 2009 | 18 | |
| 16 | Thymidine kinase 1 is a better prognostic marker than Ki-67 for pT1 adenocarcinoma of the lung. | 2014 | 18 |
| 17 | 2018 | 18 | |
| 18 | 2015 | 16 | |
| 19 | 2017 | 15 | |
| 20 | Transient increase in serum thymidine kinase 1 within one week after surgery of patients with carcinoma. | 2010 | 13 |
About Ellen He
Ellen He is a scholar working on Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Cancer Research and Biochemistry, having authored 39 papers that have together received 655 indexed citations. Recurring topics across this work include Cancer and biochemical research (10 papers), Global Cancer Incidence and Screening (6 papers), Lung Cancer Research Studies (6 papers), Lung Cancer Diagnosis and Treatment (4 papers), Inflammatory Biomarkers in Disease Prognosis (4 papers), Cancer Diagnosis and Treatment (4 papers), Breast Cancer Treatment Studies (4 papers) and Colorectal Cancer Screening and Detection (3 papers). The work is most often cited by research in Oncology (205 citations), Pathology and Forensic Medicine (126 citations), Cancer Research (84 citations), Pulmonary and Respiratory Medicine (143 citations) and Obstetrics and Gynecology (30 citations). Ellen He has collaborated with scholars based in China, Sweden and Canada. Frequent co-authors include Sven Skog, Ji Zhou, Staffan Eriksson, Yan Chen, Siamak Haghdoost, Guozhu Hu, Lili Tang, Qun-Li Shi, Hongbo Ma and Zhiheng Chen. Their work appears in journals such as Tumor Biology, European Journal of Cancer Prevention, Cancer Biomarkers, Frontiers in Endocrinology and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.